Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03603184 |
| Title | Atezolizumab Trial in Endometrial Cancer - AtTEnd (AtTEnd) |
| Acronym | AtTEnd |
| Recruitment | Active, not recruiting |
| Gender | female |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Mario Negri Institute for Pharmacological Research |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | NZL | ITA | GBR | ESP | DEU | CHE | AUT | AUS |